Facility-Associated Release of Polioviruses into Communities-Risks for the Posteradication Era.


Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 15 5 2019
medline: 24 12 2019
entrez: 15 5 2019
Statut: ppublish

Résumé

The Global Polio Eradication Initiative continues to make progress toward the eradication target. Indigenous wild poliovirus (WPV) type 2 was last detected in 1999, WPV type 3 was last detected in 2012, and over the past 2 years WPV type 1 has been detected only in parts of 2 countries (Afghanistan and Pakistan). Once the eradication of poliomyelitis is achieved, infectious and potentially infectious poliovirus materials retained in laboratories, vaccine production sites, and other storage facilities will continue to pose a risk for poliovirus reintroduction into communities. The recent breach in containment of WPV type 2 in an inactivated poliovirus vaccine manufacturing site in the Netherlands prompted this review, which summarizes information on facility-associated release of polioviruses into communities reported over >8 decades. Successful polio eradication requires the management of poliovirus containment posteradication to prevent the consequences of the reestablishment of poliovirus transmission.

Identifiants

pubmed: 31082331
doi: 10.3201/eid2507.181703
pmc: PMC6590745
doi:

Substances chimiques

Poliovirus Vaccine, Inactivated 0
Poliovirus Vaccine, Oral 0

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1363-1369

Références

Indian J Med Res. 2003 Dec;118:217-23
pubmed: 14870793
Health Lab Sci. 1976 Apr;13(2):105-14
pubmed: 946794
S Afr Med J. 1946 Nov 9;20(21):670-3
pubmed: 20278840
Euro Surveill. 2016;21(11):30169
pubmed: 27020766
N Engl J Med. 1949 Aug 4;241(5):205-13
pubmed: 18137400
Science. 1941 Aug 1;94(2431):113-4
pubmed: 17801496
Bull World Health Organ. 2004 Jan;82(1):59-62
pubmed: 15106302
J Infect Dis. 2018 Jan 17;217(3):344-346
pubmed: 29304197
Lancet. 1955 Apr 2;268(6866):702-3
pubmed: 14354975
Euro Surveill. 2017 May 25;22(21):
pubmed: 28597830
Future Microbiol. 2015;10(5):791-808
pubmed: 25824845
Clin Infect Dis. 2017 Aug 1;65(3):414-419
pubmed: 28444240
Can Med Assoc J. 1950 Nov;63(5):498-9
pubmed: 14778110
J Exp Med. 1934 Jan 31;59(2):115-36
pubmed: 19870235
N Engl J Med. 2005 Apr 7;352(14):1411-2
pubmed: 15814877
J Infect Dis. 1997 Sep;176(3):617-24
pubmed: 9291306
Am J Hyg. 1963 Jul;78:29-60
pubmed: 14043545
Annu Rev Microbiol. 1979;33:41-66
pubmed: 386929
Am J Med Sci. 1947 Jan;213(1):9-18
pubmed: 20279838
Vaccine. 2012 Dec 14;30(52):7561-5
pubmed: 23099333
Cal West Med. 1936 Feb;44(2):141-2
pubmed: 18743555
J Infect Dis. 2014 Nov 1;210 Suppl 1:S447-53
pubmed: 25316866
Biologicals. 2006 Jun;34(2):117-22
pubmed: 16650772
Am J Public Health Nations Health. 1965 Feb;55:190-9
pubmed: 14269202
J Infect Dis. 1997 Feb;175 Suppl 1:S286-92
pubmed: 9203732

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH